{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:42:51Z","timestamp":1657946571522},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,7,15]]},"DOI":"10.2169\/internalmedicine.8838-21","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T22:23:42Z","timestamp":1657837422000},"page":"2111-2116","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of a Body Mass Index Decrease during First Chemotherapy in Patients with Advanced Follicular Lymphoma"],"prefix":"10.2169","volume":"61","author":[{"given":"Makoto","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Hematology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitoyo","family":"Kagami","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Hiraga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Jaffe ES, de Jong D, Harris NL, et al. Follicular lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC, Lyon, 2017: 266-277."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Al-Tourah AJ, Gill KK, Chhanabhai M, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin&apos;s lymphoma. J Clin Oncol 26: 5165-5169, 2008.","DOI":"10.1200\/JCO.2008.16.0283"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491-497, 1980.","DOI":"10.1016\/S0149-2918(05)80001-3"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Todorov P, Cariuk P, McDevitt T, et al. Characterization of a cancer cachectic factor. Nature 379: 739-742, 1996.","DOI":"10.1038\/379739a0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bing C, Bao Y, Jenkins J, et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. PNAS 101: 2500-2505, 2004.","DOI":"10.1073\/pnas.0308647100"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Waalkes S, Merseburger AS, Kramer MW, et al. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control 21: 1905-1910, 2010.","DOI":"10.1007\/s10552-010-9618-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yang R, Cheung MC, Pedroso EF, et al. Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res 170: e75-e78, 2011.","DOI":"10.1016\/j.jss.2011.04.061"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tsang NM, Pai PC, Chuang CC, et al. Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med 5: 665-675, 2016.","DOI":"10.1002\/cam4.634"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tarella C, Caracciolo D, Gavarotti P, et al. Overweight as an adverse prognostic factor for non-Hodgkin&apos;s lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Tranplant 26: 1185-1191, 2000.","DOI":"10.1038\/sj.bmt.1702692"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Landgren O, Andren H, Nilsson B, et al. Risk profile and outcome in Hodgkin&apos;s lymphoma: is obesity beneficial? Ann Oncol 16: 838-840, 2005.","DOI":"10.1093\/annonc\/mdi145"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hong F, Habermann TM, Gordon LI, et al. The role of body mass index in survival outcome for lymphoma patients: US intergroup experience. Ann Oncol 25: 669-674, 2014.","DOI":"10.1093\/annonc\/mdt594"},{"key":"12","unstructured":"12. NCI. National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) v5.0 [Internet]. [cited 2018 Nov 8]. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kanda Y. Investigation of the freely-available easy-to-use software &quot;EZR&quot; (Easy R) for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yang Y, Liu Z, Zhang G, Wang H. A concise prognostic score system for diffuse large B-cell lymphoma: a retrospective study with long-term follow-up. Future Oncol 17: 4299-4306, 2021.","DOI":"10.2217\/fon-2020-1073"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Li Y, Yi P, Li J, et al. Increased body mass index is associated with improved overall survival in extranodal natural killer\/T-cell lymphoma, nasal type. Oncotarget 8: 4245-4256, 2017.","DOI":"10.18632\/oncotarget.13988"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Marks E, Shi Y. Duodenal-type follicular lymphoma: a clinicopathologic review. Arch Pathol Lab Med 142: 542-547, 2018.","DOI":"10.5858\/arpa.2016-0519-RS"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lanic H, Kraut-Tauzia J, Modzelewski R, et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 55: 817-823, 2014.","DOI":"10.3109\/10428194.2013.816421"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mozas P, Rivas-Delgado A, Rivero A, et al. High serum levels of IL-2R, IL-6, and TNF-\u03b1 are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. Leuk Res 94: 106371, 2020.","DOI":"10.1016\/j.leukres.2020.106371"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Elenitoba-Johnson KS, Jenson SD, Abbott RT, et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci 100: 7259-7564, 2003.","DOI":"10.1073\/pnas.1137463100"},{"key":"20","unstructured":"20. Trabal J, Leyes P, Forga M, et al. Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 25: 736-740, 2010."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. van der Meij BS, Langius JA, Smit EF, et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140: 1774-1780, 2010.","DOI":"10.3945\/jn.110.121202"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/14\/61_8838-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:21:52Z","timestamp":1657945312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/14\/61_8838-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":21,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8838-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"article-number":"8838-21"}}